Source: Bloomberg Law

Edwards Lifesciences: Edwards Lifesciences Settles Claims It Avoided Antitrust Review

Edwards Lifesciences Corp. will pay $10 million in civil penalties to resolve claims that it intentionally evaded antitrust review of its 2024 purchase of medical device maker JC Medical.

Read full article »
Annual Revenue
$5.0-10B
Employees
10-50K
Bernard J. Zovighian's photo - CEO of Edwards Lifesciences

CEO

Bernard J. Zovighian

CEO Approval Rating

73/100

Read more